- More Americans Can’t Afford Health Care, Prescriptions
- Swallowing Disorder Not Widely Known, Understood By Public
- Drug Overdose Deaths Rising Faster in Black Americans, Study Finds
- Eye Exam Can Assess Risk Of Delirium Following Surgery
- Low ‘Bad’ Cholesterol Might Protect Against Dementia, Alzheimer’s
- Experts Concerned as NIH Axes Critical Vaccine Study Funds
- Brain Implant Lets Woman Talk After 18 Years of Silence Due to Stroke
- Major Job Cuts at NIOSH Pose Risks to Worker Safety, Critics Warn
- Microplastics Linked To High Blood Pressure, Diabetes, Stroke
- Pregnant Women, New Moms Dying More Often From Heart Conditions
Boston Scientific Recalls Accolade Pacemaker Devices

Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration.
The Accolade devices under recall include the Accolade, Proponent, Essentio, and Altrua 2 Standard Life and Extended Life pacemakers and the Visionist and Valitude cardiac resynchronization therapy pacemakers.
The devices are being recalled due to an increased risk for permanently entering Safety Mode. Safety Mode has limited functionality and is associated with the pacemaker being unable to properly regulate the heart’s rhythm and rate in some patients. Devices that enter Safety Mode need to be replaced.
Due to a manufacturing issue, the battery underpowers the device and causes the device to permanently enter Safety Mode. The FDA is working with the manufacturer to assess the risk for this issue in all Accolade pacemaker devices and to pinpoint additional mitigation strategies as needed.
Serious adverse health consequences, including slow heartbeats, fainting, and death, may be caused by the recalled devices. So far, 832 injuries and two deaths have been reported.
Physicians and patients should work together to monitor Accolade pacemaker devices. For patients at high risk for harm associated with interrupted pacing that may occur with Safety Mode, the device should be immediately replaced. For other patients, nonurgent replacement is recommended. Any problems encountered with Accolade pacemaker devices should be reported to the FDA.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.